Denise Drake
Psychiatric/Mental Health · Scottsdale, AZNPI 1245598010
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,320 of the $6,676 with a category attached, or 79.7%. It is spread thinly across 21 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 196 payments — averaging $34.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$1K
- AbbVie$1K
- Alkermes, Inc.$563
- Otsuka America Pharmaceutical, Inc.$550
- Eisai Inc.$291
- plus $1K from 15 others
What the payments were for
- Consulting fees$1,29519%
- Food & beverage$5,32080%
- Education$611%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 36 | $1,338 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $1,295 |
| AbbVie | 61 | $1,218 |
| Alkermes, Inc. | 16 | $563 |
| Otsuka America Pharmaceutical, Inc. | 20 | $550 |
| Eisai Inc. | 5 | $291 |
| Axsome Therapeutics, Inc. | 6 | $247 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $244 |
| Corium, LLC | 8 | $187 |
| Johnson & Johnson | 2 | $154 |
| Lundbeck LLC | 8 | $140 |
| Neurocrine Biosciences, Inc. | 4 | $95 |
| Teva Pharmaceuticals USA, Inc. | 3 | $77 |
| Idorsia Pharmaceuticals US Inc | 3 | $60 |
| Sunovion Pharmaceuticals Inc. | 3 | $57 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Almatica Pharma LLC | 1 | $26 |
| Bausch Health US, LLC | 1 | $24 |
| Noven Therapeutics, LLC | 1 | $24 |
| Alfasigma USA, Inc. | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$1,399
- CAPLYTA$616
- VRAYLAR$363
- Dayvigo$246
- INVEGA SUSTENNA$133
- Auvelity$125
- VIVITROL$116
- ABILIFY MAINTENA$116
How this compares
$6,676 in reported general payments places this provider in the 95th percentile of 1,230 psychiatric/mental health providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion Hcl SrBupropion Hcl | 20 | $659 |
| Bupropion XlBupropion Hcl | 20 | $375 |
| Clonazepam | 27 | $319 |
| Escitalopram Oxalate | 18 | $308 |
| Gabapentin | 23 | $223 |
| Lamotrigine | 25 | $161 |
| Trazodone Hcl | 23 | $128 |
| Aripiprazole | 15 | $108 |
| Quetiapine Fumarate | 14 | $82 |
| Alprazolam | 20 | $53 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Scottsdale
- Brett LeifsonScottsdale$90K
- Bryan LazaroScottsdale$61K
- Chyllia DixonScottsdale$18K
- Susan BowenScottsdale$6K
- Elizabeth ElliottPhoenix$363K
- Diane StrickerGilbert$281K
- Russell HorningPhoenix$254K
- Stacy UnderwoodMesa$252K
- Claire ReecePhoenix$88K
- Luis FongPhoenix$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.